Omalizumab Protects against Allergen- Induced Bronchoconstriction in Allergic (Immunoglobulin E-Mediated) Asthma-Reference-Cited by-同舟云学术

Omalizumab Protects against Allergen- Induced Bronchoconstriction in Allergic (Immunoglobulin E-Mediated) Asthma

Published:2013 Issue:1 Volume:160 Page:102-110
ISSN:1423-0097
Container-title:International Archives of Allergy and Immunology
language:en
Short-container-title:Int Arch Allergy Immunol

Author:

Zielen Stefan,Lieb Adrian,De La Motte Stephan,Wagner Frank,de Monchy Jan,Fuhr Rainard,Munzu Clara,Koehne-Voss Stephan,Rivière Gilles-Jacques,Kaiser Guenther,Erpenbeck Veit J.

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Reference25 articles.

1. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation

2. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

3. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

4. Omalizumab is well tolerated in adolescent/adult patients (≥12 Years) with moderate-to-severe persistent asthma

5. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA Profiling of the Inflammatory Response after Early and Late Asthmatic Reaction;International Journal of Molecular Sciences;2024-01-22

2. Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review;Journal of Asthma and Allergy;2023-07

3. Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL;World Allergy Organization Journal;2023-06

4. A comparison of the effectiveness of biologic therapies for asthma;Annals of Allergy, Asthma & Immunology;2023-05

5. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis;Frontiers in Immunology;2023-04-11